Association of a deletion of GSTT2B with an altered risk of oesophageal squamous cell carcinoma in a South African population: A Case-Control study

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Matejcic, Marco ^a,b   Li, DongPing ^a,b   Prescott, Natalie J ^c   Lewis, Cathryn M ^c,d   Mathew, Christopher G ^c   Parker, M Iqbal ^a,b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GUY S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNICITY; GENE DELETION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GSTP GENE; GSTT1 GENE; GSTT2B GENE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; POPULATION RESEARCH; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOUTH AFRICA; DRINKING BEHAVIOR; ESOPHAGUS TUMOR; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

GLUTATHIONE TRANSFERASE; GSTT2 PROTEIN, HUMAN;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; SOUTH AFRICA;

EID: 84455192416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029366     Document Type: Article

References (43)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2011) SEER Cancer Statistics Review 1975-2008 Bethesda, MD National Cancer Institute Available: http://seer.cancer.gov/csr/1975_2008/. Accessed 2011 Apr 15.
2. Day NE, Varghese C, (1994) Oesophageal cancer. Cancer Surv 19-20: 43-54.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
4. Rankin SheilaC, (2008) Carcinoma of the Esophagus Cambridge Cambridge University Press.
5. Ma WJ, Lv GD, Zheng ST, Huang CG, Liu Q, et al. (2010) DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China. World J Gastroenterol 16: 641-647.
6. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F, (2007) Esophageal Cancer in Northeastern Iran: A Review. Arch Iran Med 10: 70-82.
7. Venters FS, (1993) Oesophageal cancer in three regions of South Africa. S Afr Med J 83: 808-810.
8. Hendricks D, Parker MI, (2002) Oesophageal cancer in Africa. IUBMB Life 53: 263-268.
9. Dlamini Z, Bhoola K, (2005) Esophageal cancer in African blacks of Kwazulu Natal, South Africa: an epidemiological brief. Ethn Dis 15: 786-789.
10. Ishiguro S, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, et al. (2009) Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett 275: 240-246.
11. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, et al. (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165: 1424-1433.
12. Li DP, Dandara C, Walther G, Parker MI, (2008) Genetic polymorphisms of alcohol metabolizing enzymes: their role in susceptibility to oesophageal cancer. Clin Chem Lab Med 46: 323-328.
13. Dandara C, Li DP, Walther G, Parker MI, (2006) Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus. Carcinogenesis 27: 791-797.
14. Li DP, Dandara C, Parker MI, (2005) Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus. Clin Chem Lab Med 43: 370-375.
15. Li DP, Dandara C, Parker MI, (2010) The 341C/T polymorphism in the GSTP1 gene is associated with increate risk of oesophageal cancer. BMC Genet 11: 47.
16. Eaton DL, Bammler TK, (1999) Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49: 156-164.
17. Douglas KT, (1987) Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol 59: 103-167.
18. Parl FF, (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett 221: 123-129.
19. Coggan M, Whitbread L, Whittington A, Board P, (1998) Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex. Biochem J 334: 617-623.
20. Whittington A, Vichai V, Webb G, Baker R, Pearson W, et al. (1999) Gene structure, expression and chromosomal localization of murine theta class glutathione transferase mGSTT1-1. Biochem J 337: 141-151.
21. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, et al. (2000) Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10: 557-565.
22. Zhao Y, Marotta M, Eichler EE, Eng C, Tanaka H, (2009) Linkage disequilibrium between two high- frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes. PLoS Genet 5: e1000472.
23. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, et al. (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10: 1239-1248.
24. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, et al. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16: 1243-1245.
25. Santovito A, Burgarello C, Cervella P, Delpero M, (2010) Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 genes in Ouangolodougou (Northern Ivory Coast). Genet Mol Biol 33: 434-437.
26. Dandara C, Sayi J, Masimirembwa CM, Magimba A, Kaaya S, et al. (2002) Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin Chem Lab Med 40: 952-957.
27. Adams CH, Werely CJ, Victor TC, Hoal EG, Rossouw G, et al. (2003) Allele frequencies for glutathione S-transferase and N-acetyltranferase 2 differ in African population groups and may be associated with esophageal cancer or tuberculosis incidence. Clin Chem Lab Med 41: 600-605.
28. Nakajima T, Wang RS, Nimura Y, Pin YM, He M, et al. (1996) Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous cell carcinomas. Carcinogenesis 17: 1477-1481.
29. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA, (1998) Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-280.
30. Dufour C, Svahn J, Bacigalupo A, Longoni D, Varotto S, et al. (2005) Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients. Haematologica 90: 1027-1031.
31. Schneider J, Bernges U, Philipp M, Woitowitz HJ, (2004) GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 208: 65-74.
32. Voho A, Impivaara O, Jarvisalo J, Metsola K, Vainio H, et al. (2006) Distribution of glutathione S- transferase M1, P1 and T1 genotypes in different age-group of Finns without diagnosed cancer. Cancer Detect Prev 30: 144-151.
33. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, et al. (2005) Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 131: 238-242.
34. McIlwain CC, Townsend DM, Tew KD, (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648.
35. Yang CX, Matsuo K, Wang ZM, Tajima K, (2005) Phase I/II enzyme polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol 11: 2531-2538.
36. Rossini A, Rapozo DC, Soares Lima SC, Guimarães DP, Ferreira MA, et al. (2007) Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. Carcinogenesis 28: 2537-2542.
37. Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, et al. (2009) Genetic polymorphism of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers. Cancer Causes Control 20: 2031-2038.
38. Adhikari M, (2005) Contending Approaches to Coloured Identity and the History of the Coloured People of South Africa. History Compass 177: 1-16.
39. Bruhn C, Brockmöller J, Kerb R, Roots I, Borchert HH, (1998) Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 56: 1189-1193.
40. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, et al. (2009) The genetic structure and history of Africans and African Americans. Science 324: 1035-1044.
41. Gustafson S, Proper JA, Bowie EJ, Sommer SS, (1987) Parameters affecting the yield of DNA from human blood. Anal Biochem 165: 294-299.
42. Rodriguez S, Gaunt TR, Day IN, (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169: 505-514.
43. Dudbridge F, (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98.